Impact of Liver Indicators on Clinical Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation Daniel Wendt, MD, Philipp Kahlert, MD, Ali Canbay, MD, Stephan Knipp, MD, Martin Thoenes, MD, Gordina Cremer, Fadi Al-Rashid, MD, Rolf-Alexander Jánosi, MD, Karim El-Chilali, MD, Markus Kamler, MD, Mohamed El Gabry, MD, Philipp Marx, MD, Daniel Sebastian Dohle, MD, Konstantinos Tsagakis, MD, Jaroslav Benedik, MD, Guido Gerken, MD, Tienush Rassaf, MD, Heinz Jakob, MD, Matthias Thielmann, MD The Annals of Thoracic Surgery Volume 104, Issue 4, Pages 1357-1364 (October 2017) DOI: 10.1016/j.athoracsur.2017.02.075 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Values (in U/L) of alanine aminotransferase (ALT; dotted line), aspartate aminotransferase (AST; dashed line), and γ-glutamyl transpeptidase (GGT; black line) compared between (p value) patients presenting with and without liver chronic liver disease. The Annals of Thoracic Surgery 2017 104, 1357-1364DOI: (10.1016/j.athoracsur.2017.02.075) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Values of bilirubin (mg/dL; black line) and international normalized ratio (INR; dotted line) compared between patients (p value) presenting with and without liver chronic liver disease. The Annals of Thoracic Surgery 2017 104, 1357-1364DOI: (10.1016/j.athoracsur.2017.02.075) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier survival curve for patients with chronic liver disease. The Annals of Thoracic Surgery 2017 104, 1357-1364DOI: (10.1016/j.athoracsur.2017.02.075) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions